Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus and anti-phospholipid syndrome

Lupus

Volumn 19, Issue 2, 2010, Pages 206-209

  Chang, P C ^a   Chen, W S ^a,b   Lin, H Y ^a,b   Lee, H M ^a,b   Chen, S J ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Anti phospholipid syndrome; Central retinal artery occlusion; Central retinal vein occlusion; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN ANTIBODY; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE; PREDNISOLONE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; DEEP VEIN THROMBOSIS; DRUG PULSE THERAPY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HEMATURIA; HEMODYNAMICS; HEMOLYTIC ANEMIA; HUMAN; LEUKOPENIA; LUNG EMBOLISM; OPTIC NEURITIS; PRIORITY JOURNAL; RETINA EDEMA; RETINA HEMORRHAGE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; SEVERITY OF ILLNESS INDEX; VISUAL ACUITY;

EID: 76049109533     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309345751     Document Type: Article

References (8)

1. Miyakis S., Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4: 295-306.
2. Kleiner RC, Najarian LV, Schatten S., et al. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 1989 ; 96: 896-904.
3. Au A., O?Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Exp Ophthalmol 2004 ; 32: 87-100.
4. Fitzpatrick EP, Chesen N., Rahn EK The lupus anticoagulant and retinal vaso-occlusive disease. Ann Ophthalmol 1990 ; 22: 148-152.
5. Durukan AH, Akar Y., Bayraktar MZ, Dinc A., Sahin OF Combined retinal artery and vein occlusion in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Can J Ophthalmol 2005 ; 40: 87-89.
6. Jabs DA, Fine SL, et al. Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol 1986 ; 104: 558-563.
7. Iijima H., Tsumura T. Combined occlusion of the central retinal artery and vein. Jpn J Ophthalmol 1994 ; 38: 202-207.
8. Perez-Vazquez ME, Villa AR, Drenkard C., Cabiedes J., Alarcon-Segovia D. Influence of disease duration, continued follow-up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. J Rheumatol 1993 ; 20: 437-442.